BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 23681073)

  • 1. Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
    Chernock RD; El-Mofty SK; Becker N; Lewis JS
    Am J Surg Pathol; 2013 Aug; 37(8):1215-22. PubMed ID: 23681073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
    Ye J; Hameed O; Findeis-Hosey JJ; Fan L; Li F; McMahon LA; Yang Q; Wang HL; Xu H
    Biotech Histochem; 2012 Jan; 87(1):30-4. PubMed ID: 21838611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
    El-Maqsoud NM; Tawfiek ER; Abdelmeged A; Rahman MF; Moustafa AA
    Tumour Biol; 2016 Mar; 37(3):3123-34. PubMed ID: 26427663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
    Iwamoto M; Nakatani Y; Fugo K; Kishimoto T; Kiyokawa T
    Hum Pathol; 2015 Jul; 46(7):957-62. PubMed ID: 25971546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
    Ramos-Vara JA; Frank CB; DuSold D; Miller MA
    J Comp Pathol; 2016 Nov; 155(4):286-298. PubMed ID: 27567273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
    Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
    Bishop JA; Sharma R; Illei PB
    Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
    Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
    Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
    Wu J; Zhang Y; Ding T; Cheng R; Gong W; Guo Y; Luo Y; Pan Y; Zhai Q; Sun W; Lin D; Sun B
    Endocr Pathol; 2020 Mar; 31(1):39-45. PubMed ID: 31788765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.
    Nonaka D; Tang Y; Chiriboga L; Rivera M; Ghossein R
    Mod Pathol; 2008 Feb; 21(2):192-200. PubMed ID: 18084247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
    Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK
    Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin.
    Kim MY; Go H; Koh J; Lee K; Min HS; Kim MA; Jeon YK; Lee HS; Moon KC; Park SY; Kim WH; Chung DH
    Histopathology; 2014 Aug; 65(2):195-206. PubMed ID: 24479710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck.
    Bishop JA; Sharma R; Westra WH
    Hum Pathol; 2011 Dec; 42(12):1873-7. PubMed ID: 21663937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.
    Kadivar M; Boozari B
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):191-5. PubMed ID: 22914608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A word of caution regarding napsin A expression in squamous cell carcinomas of the lung.
    Ordóñez NG
    Am J Surg Pathol; 2012 Mar; 36(3):396-401. PubMed ID: 22198009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
    Sharifai N; Abro B; Chen JF; Zhao M; He H; Cao D
    Hum Pathol; 2020 Aug; 102():23-32. PubMed ID: 32561332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant Protein A and Napsin A in the Immunohistochemical Characterization of Canine Pulmonary Carcinomas: Comparison With Thyroid Transcription Factor-1.
    Beck J; Miller MA; Frank C; DuSold D; Ramos-Vara JA
    Vet Pathol; 2017 Sep; 54(5):767-774. PubMed ID: 28578631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
    Stoll LM; Johnson MW; Gabrielson E; Askin F; Clark DP; Li QK
    Cancer Cytopathol; 2010 Dec; 118(6):441-9. PubMed ID: 20830690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms.
    Fabbro D; Di Loreto C; Beltrami CA; Belfiore A; Di Lauro R; Damante G
    Cancer Res; 1994 Sep; 54(17):4744-9. PubMed ID: 8062273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.